Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

180.37
Delayed Data
As of Feb 27
 -2.74 / -1.50%
Today’s Change
136.37
Today|||52-Week Range
203.30
-2.52%
Year-to-Date

Today’s Trading

Previous close183.11
Today’s open183.08
Day’s range179.44 - 183.99
Volume944,706
Average volume (3 months)1,267,470
Market cap$36.5B
Dividend yield--
Data as of 4:14pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+13.57%
Earnings growth (next 5 years)+21.19%
Revenue growth (last year)+45.40%
P/E ratio55.3
Price/Sales16.67
Price/Book10.87

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.54-0.45%
SHPGShire-5.93-2.39%
ZTSZoetis Inc-0.53-1.14%
PRGOPerrigo Company PLC-0.78-0.50%
Data as of 4:14pm ET, 02/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.33
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account